Board approves name change, adds pharma and chemicals to business objects
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.5 pts less than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sattva Sukun Lifecare board approved a proposed name change to Tavexia, Trumaxa, Trustarex or Tradamex Lifecare Limited, subject to CRC and shareholder approval. The Object Clause of the MOA was also expanded to add businesses in chemicals, specialty chemicals, pharmaceuticals, APIs, nutraceuticals, biotech, CRO/CDMO/CRAMS services, R&D and intellectual property. Two directors, Sachin Manseta and Chirag Dedhia, were regularized for 5-year terms from July 22, 2026. An EGM will be held to seek shareholder approval for these changes.
Name change and widened business scope suggest a strategic shift into pharma and chemicals; outcomes hinge on shareholder and regulatory approvals.